Inpatient Palliative Care Improves QoL for Patients Hospitalized for HCT

Inpatient Palliative Care Improves QoL for Patients Hospitalized for HCT
Inpatient Palliative Care Improves QoL for Patients Hospitalized for HCT

Palliative care improved quality of life, depression, anxiety, and symptom burden in patients with hematologic malignancies hospitalized for hematopoietic stem cell transplantation (HCT), a study presented at the 2016 Palliative Care in Oncology Symposium has shown.1

During HCT, patients often experience physical and psychosocial symptoms that negatively affect their quality of life. Therefore, researchers sought to evaluate how an inpatient palliative care intervention impacts quality of life, symptom burden, and mood during hospitalization for HCT and at 3 months following HCT.

Continue Reading Below

For the study, investigators enrolled 160 patients with hematologic malignancies admitted for autologous or allogeneic HCT. Participants were randomly assigned 1:1 to an inpatient palliative care intervention integrated with transplant care or transplant care alone.

Quality of life was assessed using the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT), while the Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire (PHQ-9) were used to measure mood.

Results showed that week-2, patients in the palliative care intervention group reported improvements in quality of life, depression, anxiety, and symptom burden.

At 3 months post-HCT, patients who received palliative care had significantly improved quality of life, depression, and posttraumatic stress symptoms compared with those who did not. There was no significant difference in anxiety scores between the 2 groups.

Reference

1. El-Jawahri A, LeBlanc TW, VanDusen H, et al. Randomized trial of inpatient palliative care in patients hospitalized for hematopoietic stem cell transplantation (HCT). Poster presented at: 2016 Palliative Care in Oncology Symposium; September 9-10, 2016; San Francisco, CA.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs